<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-04-25798">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2004_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2010-09-23</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Current Good Tissue Practice for Human Cell, Tissue, and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement</title>
        <partNumber>Part IV</partNumber>
        <partName>Rules and Regulations</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2004-11-24/html/04-25798.htm">
        <identifier type="FDsys Unique ID">D09002ee1c8126ea9</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2004-11-24/pdf/04-25798.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c8126faf</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Food and Drug Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Food and Drug Administration (FDA) is requiring human cell, tissue, and cellular and tissue-based product (HCT/P) establishments to follow current good tissue practice (CGTP), which governs the methods used in, and the facilities and controls used for, the manufacture of HCT/Ps; recordkeeping; and the establishment of a quality program. The agency is also issuing new regulations pertaining to labeling, reporting, inspections, and enforcement that will apply to manufacturers of those HCT/Ps regulated solely under the authority of the Public Health Service Act (PHS Act), and not as drugs, devices, and/or biological products. The agency's actions are intended to improve protection of the public health while keeping regulatory burden to a minimum, which in turn would encourage significant innovation.</abstract>
    <identifier type="FR citation">69 FR 68612</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2004-11-24/04-25798</identifier>
    <identifier type="FR Doc No.">04-25798</identifier>
    <identifier type="former granule identifier">fr24no04-9</identifier>
    <identifier type="billing code">4160-01-S</identifier>
    <identifier type="department code">Docket No. 1997N-484P</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2004-11-24/04-25798</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2004-11-24/html/04-25798.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2004-11-24/pdf/04-25798.pdf</url>
    </location>
    <subject>
        <topic>Communicable Diseases</topic>
        <topic>HIV/AIDS</topic>
        <topic>Reporting and Recordkeeping Requirements</topic>
        <topic>Human Cells</topic>
        <topic>Tissues</topic>
        <topic>Cellular and Tissue-Based Products</topic>
        <topic>Administrative Practice and Procedure</topic>
    </subject>
    <physicalDescription>
        <extent>77 p.</extent>
    </physicalDescription>
    <part type="Part IV">
        <extent unit="pages">
            <start>68612</start>
            <end>68688</end>
        </extent>
    </part>
    <identifier type="preferred citation">69 FR 68612</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 1270</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  1270</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 1271</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  1271</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 16</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  16</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Current Good Tissue Practice for Human Cell, Tissue, and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement; Federal Register Vol. 69, Issue </searchTitle>
        <granuleClass>RULE</granuleClass>
        <accessId>04-25798</accessId>
        <partNumber>IV</partNumber>
        <agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="2">Food and Drug Administration</agency>
        <effectiveDate>2005-05-25</effectiveDate>
        <departmentDoc>Docket No. 1997N-484P</departmentDoc>
        <billingCode>4160-01-S</billingCode>
        <frDocNumber>04-25798</frDocNumber>
        <action>Final rule.</action>
        <summary>The Food and Drug Administration (FDA) is requiring human cell, tissue, and cellular and tissue-based product (HCT/P) establishments to follow current good tissue practice (CGTP), which governs the methods used in, and the facilities and controls used for, the manufacture of HCT/Ps; recordkeeping; and the establishment of a quality program. The agency is also issuing new regulations pertaining to labeling, reporting, inspections, and enforcement that will apply to manufacturers of those HCT/Ps regulated solely under the authority of the Public Health Service Act (PHS Act), and not as drugs, devices, and/or biological products. The agency's actions are intended to improve protection of the public health while keeping regulatory burden to a minimum, which in turn would encourage significant innovation.</summary>
        <dates>This rule is effective May 25, 2005.</dates>
        <contact>Paula S. McKeever, Center for Biologics Evaluation and Research (HFM-17), Food and Drug Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852- 1448, 301-827-6210.</contact>
        <cfr title="21">
                                    
            <part number="1270"/>
                                    
            <subject>Communicable Diseases</subject>
                                    
            <subject>HIV/AIDS</subject>
                                    
            <subject>Reporting and Recordkeeping Requirements</subject>
                                
        </cfr>
        <cfr title="21">
                                    
            <part number="1271"/>
                                    
            <subject>Human Cells</subject>
                                    
            <subject>Tissues</subject>
                                    
            <subject>Cellular and Tissue-Based Products</subject>
                                
        </cfr>
        <cfr title="21">
                                    
            <part number="16"/>
                                    
            <subject>Administrative Practice and Procedure</subject>
                                
        </cfr>
        <tocSubject1>Biological products:</tocSubject1>
        <tocDoc>Human cellular and tissue-based products manufacturers; current good tissue practice; inspection and enforcement, </tocDoc>
        <urlRef>http://www.bls.gov</urlRef>
        <urlRef>http://www.bls.gov/cpi</urlRef>
        <urlRef>http://www.fda.gov/cber/biodev/biodevsub.htm</urlRef>
        <urlRef>http://www.fda.gov/cber/biodev/bpdrform.pdf</urlRef>
        <urlRef>http://www.fda.gov/cber/gdlns/steraseptic.htm</urlRef>
        <urlRef>http://www.fda.gov/cber/tissue/docs.htm</urlRef>
        <urlRef>http://www.fda.gov/cber/tissue/min.htm</urlRef>
        <urlRef>http://www.fda.gov/cber/tissue/tisreg.htm</urlRef>
        <urlRef>http://www.fda.gov/medwatch</urlRef>
        <urlRef>http://www.fda.gov/opacom/morechoices/fdaforms/cber.html</urlRef>
        <urlRef>http://www.hcup-us.ahrq.gov/nisoverview.jsp</urlRef>
        <urlRef>http://www.hhs.gov/forms</urlRef>
        <urlRef>http://www.naics.com</urlRef>
        <urlRef>http://www.thespermbankofca.org/fees.html</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee18097f450" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2004-11-24/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 69, no. 226</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2004-11-24</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>525 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2004-11-24">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2004-11-24</identifier>
        <identifier type="local">P0b002ee18097f450</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr24no04</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2004-11-24</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2004-11-24/pdf/FR-2004-11-24.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2004-11-24/xml/FR-2004-11-24.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>68237</start>
                <end>68753</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2010-09-23</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-06</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2004-11-24</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2004-11-24</accessId>
            <volume>69</volume>
            <issue>226</issue>
        </extension>
    </relatedItem>
</mods>
